PREMEDICATION, BY INTRAMUSCULAR OR INTRAVENOUS INJECTION, 200-400 MICROGRAMS OR 4-5 MICROGRAMS/KG (MAX. 400 MICROGRAMS); CHILD BY INTRAMUSCULAR OR BY INTRAVENOUS INJECTION, 4-8 MICROGRAMS/KG (MAX. 200 MICROGRAMS)
INTRA-OPERATIVE USE, BY INTRAVENOUS INJECTION, 200-400 MICROGRAMS OR 4-5 MICROGRAMS/KG (MAX. 400 MICROGRAMS), REPEATED IF NECESSARY; CHILD UNDER 18 YEARS 4-8 MICROGRAMS/KG (MAX. 200 MICROGRAMS), REPEATED IF NECESSARY
CONTROL OF MUSCARINIC SIDE-EFFECTS OF NEOSTIGMINE IN REVERSAL OF NON-DEPOLARISING NEUROMUSCULAR BLOCK, BY INTRAVENOUS INJECTION, 200 MICROGRAMS PER 1 MG OF NEOSTIGMINE, OR 10-15 MICROGRAMS/KG; CHILD 10 MICROGRAMS/KG